{
    "organizations": [],
    "uuid": "180840d9abb32ec0ea0e5b4d3a7fc4140b1782f9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-horizon-pharma-q1-non-gaap-earning/brief-horizon-pharma-q1-non-gaap-earnings-per-share-0-03-idUSASC0A0WX",
    "ord_in_thread": 0,
    "title": "BRIEF-Horizon Pharma Q1 Non-Gaap Earnings Per Share $0.03",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Horizon Pharma PLC:\n* REPORTS STRONG FIRST-QUARTER 2018 ORPHAN AND RHEUMATOLOGY NET SALES GROWTH; INCREASES FULL-YEAR 2018 GUIDANCE AND ANNOUNCES NEW COMPANY OPERATING STRUCTURE TO ENHANCE FOCUS ON RARE DISEASES\n* SEES FY 2018 SALES $1.17 BILLION TO $1.2 BILLION * Q1 NON-GAAP EARNINGS PER SHARE $0.03\n* Q1 GAAP LOSS PER SHARE $0.96 * Q1 SALES $223.9 MILLION VERSUS I/B/E/S VIEW $233.1 MILLION\n* Q1 EARNINGS PER SHARE VIEW $0.06 â€” THOMSON REUTERS I/B/E/S\n* SEES 2018 ADJUSTED EBITDA GUIDANCE RANGE TO $390 MILLION TO $415 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T19:16:00.000+03:00",
    "crawled": "2018-05-10T17:43:45.066+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "horizon",
        "pharma",
        "plc",
        "report",
        "strong",
        "orphan",
        "rheumatology",
        "net",
        "sale",
        "growth",
        "increase",
        "guidance",
        "announces",
        "new",
        "company",
        "operating",
        "structure",
        "enhance",
        "focus",
        "rare",
        "disease",
        "see",
        "fy",
        "sale",
        "billion",
        "billion",
        "q1",
        "earnings",
        "per",
        "share",
        "q1",
        "gaap",
        "loss",
        "per",
        "share",
        "q1",
        "sale",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "see",
        "adjusted",
        "ebitda",
        "guidance",
        "range",
        "million",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}